Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.10T
Market cap1.10T
Price-Earnings ratio
41.63
Price-Earnings ratio41.63
Dividend yield
0.56%
Dividend yield0.56%
Average volume
2.53M
Average volume2.53M
High today
$1,189.07
High today$1,189.07
Low today
$1,141.20
Low today$1,141.20
Open price
$1,162.27
Open price$1,162.27
Volume
2.79M
Volume2.79M
52 Week high
$1,249.45
52 Week high$1,249.45
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,173.00. The company's market cap stands at 1.1T, with a P/E ratio of 41.63 and a dividend yield of 0.56%.

During the trading session on 2026-07-17, Eli Lilly(LLY) shares reached a daily high of $1,189.07 and a low of $1,141.20. At a current price of $1,173.00, the stock is +2.8% higher than the low and still -1.4% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 2.79M, versus its average volume of 2.53M.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

LLY News

Simply Wall St 3h
AtaiBeckley Agrees To Eli Lilly Buyout With Milestone Upside For Shareholders

Eli Lilly has signed a definitive agreement to acquire psychedelic drug developer AtaiBeckley (NasdaqGM:ATAI). The deal includes upfront cash plus contingent v...

AtaiBeckley Agrees To Eli Lilly Buyout With Milestone Upside For Shareholders
Simply Wall St 5h
Mental Health Stocks Gaining Fresh Attention After Eli Lilly’s Psychedelic Deal

The Eli Lilly move on AtaiBeckley has pushed psychedelics and mental health treatments back into the spotlight, and it is giving investors fresh reasons to reas...

Mental Health Stocks Gaining Fresh Attention After Eli Lilly’s Psychedelic Deal
Nasdaq 7h
Why AtaiBeckley Stock Soared Today

Key Points AtaiBeckley is developing a promising depression treatment. Eli Lilly has long been a leader in neuroscience. The two companies want to work toget...

Why AtaiBeckley Stock Soared Today

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

Nasdaq 8h
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion

AtaiBeckley (NASDAQ:ATAI), a clinical-stage mental health and psychedelic drug developer, closed at $7.15, up 33.4%. Eli Lilly’s (NYSE:LLY) announced acquisitio...

Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion
TipRanks 13h
Lilly Quietly Expands Its Obesity Pipeline With New Early-Stage LY4174794 Trial

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...

TipRanks 13h
Lilly-Backed Gene Therapy Study Tracks Long Term Safety in Vestibular Schwannoma

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...

TipRanks 13h
Eli Lilly Expands Obesity Pipeline With New Phase 1 Eloralintide Trial

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...

TipRanks 13h
Lilly’s Tersolisib Food-Effect Study Moves Forward, Adding Depth to Its Early-Stage Pipeline

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...

TipRanks 15h
Why Is AtaiBeckley N.V. Stock Up Today?

AtaiBeckley N.V. (ATAI) stock surged on Thursday after the clinical-stage biopharmaceutical company announced an acquisition agreement with global pharmaceutica...

Nasdaq 16h
Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?

Key Points Johnson & Johnson maintains a diversified presence across innovative medicine and medical technology, generating significant cash flow. Eli Lilly i...

Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.